Frequently bought together

Brand : SCOPINAL

SCOPINAL 10/MG FC TAB 20/FC TAB

Sku : I-005762
Key features
SCOPINAL 10 mg film-coated tablets contain the active ingredient hyoscine butylbromide 10 mg. It works by competitively antagonizing muscarinic acetylcholine receptors on peripheral smooth muscle (gastrointestinal, biliary and genitourinary tracts), reducing spasms while exhibiting minimal central nervous system penetration due to its quaternary ammonium structure. SCOPINAL is indicated for symptomatic relief of smooth‑muscle spasms, including irritable bowel syndrome, biliary colic/spasm, renal/ureteric colic and spasmodic dysmenorrhea. Available OTC as film‑coated tablets in a pack of 20.
- Brand: SCOPINAL
- Active Ingredient: HYOSCINE BUTYLBROMIDE 10mg
- Strength: 10mg
- Dosage Form: Film-coated tablet
- Pack Size: 20 Tablets
- Route: Oral use
- Prescription Status: OTC
- Therapeutic Class: Alimentary Tract & Metabolism
- Drug Class: Antispasmodic; peripherally acting antimuscarinic (anticholinergic) quaternary ammonium compound.
- Manufacturer: Gulf Pharmaceutical Industries (Julphar)
- Country of Origin: United Arab Emirates
- SFDA Registration No.: 0909258202
- Shelf Life: 36 months
- Storage: store below 25°c
- Gi Condition: IBS

Frequently bought together

Description

Specification

Indications

Approved Uses

Symptomatic relief of smooth‑muscle spasm of the gastrointestinal tract (including IBS), biliary tract (biliary colic/spasm), and genitourinary tract (e.g., renal/ureteric colic); may be used for spasmodic dysmenorrhea.

Dosage & Administration

Children's Dosage

Children 6-12 years: 10 mg up to 3 times daily; Not recommended under 6 years for oral tablets

Safety & Warnings

Age Restriction

Not recommended for children under 6 years.

Special Populations

Children

Children 6-12 years: 10 mg up to 3 times daily; Not recommended under 6 years for oral tablets

Pharmacology

Mechanism of Action

Competitive antagonism at muscarinic acetylcholine receptors in peripheral smooth muscle (GI, biliary, and genitourinary tracts), reducing spasms; minimal CNS penetration due to quaternary ammonium structure.

Onset of Action

Oral onset typically within 30-60 minutes.

Half-Life

The half life of elimination is 1-5 hours.

Bioavailability

Very low oral bioavailability, generally <1%.

Product Information

Available Dosage Forms

Film-coated tablet, solution for injection

Composition per Dose

Each film-coated tablet: 10 mg hyoscine butylbromide

Generic Availability

Yes

Gi Condition

IBS

Legal Disclaimer - Al Mujtama Pharmacy

The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.

Al Mujtama Pharmacy assumes no legal or medical liability for:

Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
Any discrepancy between the information provided and the product's package insert or SFDA guidelines
Any misuse of medication resulting from personal interpretation of the content displayed

Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.

By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.

Your health is a trust - always consult your doctor first.